Cite
HARVARD Citation
Mosley, S. et al. (2022). A randomized, cross‐over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalence. Clinical and translational science. 15 (7), pp. 1764-1775. [Online].